AMAgnes Marot-Leblond

Agnes Marot-Leblond

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Agnes Marot-Leblond has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Raymond Robert

    L'UNAM Université, Université d'Angers, Groupe d'Etude des Interactions Hôte-Pathogène, EA 3142, Institut de Biologie en Santé-IRIS, Angers, France

    4 shared publications
  • Linda Grimaud

    Groupe d'Etude des Interactions Hôte-Parasite, UPRES EA 3142, UFR des Sciences Pharmaceutiques et d'Ingénierie de la Santé, Angers,1 SR2B, ZI Carrière Beurrière, Avrillé, France,2 Department of Oral Surgery, Oral Medicine and Oral Pathology, School of Dental Science, Trinity College, University of Dublin, Dublin, Republic of Ireland,3 Departementado de Immunologia, Microbiologia y Pathologia, Facultad de Medicina y Odontologia, Universidad del Pais, Vasco, Spain4

    2 shared publications
  • Alphonse Calenda

    Univ Angers, IRF, SFR ICAT, F-49000 Angers, France

    1 shared publication
  • Bernard Cimon

    L'UNAM Université, Université d'Angers, Groupe d'Etude des Interactions Hôte-Pathogène, EA 3142, Institut de Biologie en Santé-IRIS, Angers, France L'UNAM Université, Centre Hospitalier Universitaire d'Angers, Laboratoire de Parasitologie-Mycologie, Institut de Biologie en Santé-PBH, CHU, Angers, France

    1 shared publication
  • Corinne Lefrançois

    Groupe d'Etude des Interactions Hôte-Parasite, UPRES EA 3142, UFR des Sciences Pharmaceutiques et d'Ingénierie de la Santé, 16 Bd Daviers, 49045 Angers Cedex, France

    1 shared publication
  • Daniel Poulain

    INSERM U1285, CNRS UMR 8576, Glycobiology in Fungal Pathogenesis and Clinical Applications, Université de Lille, F-59000 Lille, France

    1 shared publication

Latest Publications

  • Open Access

    A Stress Hub in Scedosporium apiospermum: The High Osmolarity Glycerol (HOG) Pathway

    by Hajar Yaakoub, Sara Mina, Agnès Marot, Nicolas Papon, Alphonse Calenda, Jean-Philippe Bouchara

    Scedosporium species are opportunistic filamentous fungi found in human-impacted areas. Clinically relevant species, such as S. apiospermum, rank as the second most frequent colonizers of the airways of patients with cystic fibrosis (CF), which are characterized by persistent oxidative stress. This raises the question of how Scedosporium species abate conditions imposed in hostile environments. Since the High Osmolarity Glycerol (HOG) pathway plays a central role in fungal adaptation to stress, we aimed to pheno-profile the involvement of the pathway in response to stress in S. apiospermum using Western blot. We show for the first time that a wide range of stress distinctively activates the HOG pathway in S. apiospermum, including oxidants (H2O2, menadione, cumene hydroperoxide, diamide, paraquat, and honokiol), osmotic agents (sorbitol and KCl), cell-wall stress agents (caffeine, calcofluor white, and Congo Red), heavy metals (cadmium and arsenite), fungicides (fludioxonil and iprodione), antifungals (voriconazole and amphotericin B), and acid stress (pH 4). We suggest that the function of the HOG pathway as a general stress regulator is also conserved in S. apiospermum.


  • Open Access

    Purification and Characterization of a Mycelial Catalase from Scedosporium boydii, a Useful Tool for Specific Antibody Detection in Patients with Cystic Fibrosis

    by Sara Mina, Agnès Marot-Leblond, Bernard Cimon, Maxime J J Fleury, Gérald Larcher, Jean-Philippe Bouchara, Raymond Robert

    Scedosporium boydiiis an opportunistic filamentous fungus which may be responsible for a wide variety of infections in immunocompetent and immunocompromised individuals. This fungus belongs to theScedosporium apiospermumspecies complex, which usually ranks second among the filamentous fungi colonizing the airways of patients with cystic fibrosis (CF) and may lead to allergic bronchopulmonary mycoses, sensitization, or respiratory infections. Upon microbial infection, host phagocytic cells release reactive oxygen species (ROS), such as hydrogen peroxide, as part of the antimicrobial response. Catalases are known to protect pathogens against ROS by detoxification of the hydrogen peroxide. Here, we investigated the catalase equipment ofScedosporium boydii, one of the major pathogenic species in theS. apiospermumspecies complex. Three catalases were identified, and the mycelial catalase A1 was purified to homogeneity by a three-step chromatographic process. This enzyme is a monofunctional tetrameric protein of 460 kDa, consisting of four 82-kDa glycosylated subunits. The potential usefulness of this enzyme in serodiagnosis ofS. apiospermuminfections was then investigated by an enzyme-linked immunosorbent assay (ELISA), using 64 serum samples from CF patients. Whatever the species involved in theS. apiospermumcomplex, sera from infected patients were clearly differentiated from sera from patients with anAspergillus fumigatusinfection or those from CF patients without clinical and biological signs of a fungal infection and without any fungus recovered from sputum samples. These results suggest that catalase A1 is a good candidate for the development of an immunoassay for serodiagnosis of infections caused by theS. apiospermumcomplex in patients with CF.


  • Open Access

    Evaluation of an immunomagnetic separation method to capture Candida yeasts cells in blood

    by Véronique Apaire-Marchais, Marie Kempf, Corinne Lefrançois, Agnès Marot, Patricia Licznar, Jane Cottin, Daniel Poulain, Raymond Robert

    Candida species have become the fourth most-frequent cause of nosocomial bloodstream infections in immunocompromised patients. Therefore, rapid identification of pathogenic fungi to species level has been considered critical for treatment. Conventional diagnostic procedures such as blood culture or biochemical tests are lacking both sensitivity and species specificity, so development of rapid diagnostic is essential.


  • Evaluation of a Rapid Immunochromatographic Assay for Identification of Candida albicans and Candida dubliniensis

    by Agnes Marot-Leblond, Linda Grimaud, Sandrine David, Derek J. Sullivan, David C. Coleman, Jose Ponton, Raymond Robert

    Candida dubliniensis was first established as a novel yeast species in 1995. It is particularly associated with recurrent episodes of oral candidosis in human immunodeficiency virus (HIV)-infected patients, but it has also been detected at other anatomical sites and at a low incidence level in non-HIV-infected patients. It shares so many phenotypic characteristics with C. albicans that it is easily misidentified as such. No rapid, simple, and commercial test that allows differentiation between C. dubliniensis and C. albicans has been developed, until now. Accurate species identification requires the use of genotype-based techniques that are not routinely available in most clinical microbiology diagnostic laboratories. The present study was designed to evaluate the efficiency of a new test (the immunochromatographic membrane [ICM] albi-dubli test; SR2B, Avrillé, France) to differentiate between C. albicans and C. dubliniensis . The organisms evaluated were strains whose identities had previously been confirmed by PCR tests and freshly isolated clinical strains and included 58 C. albicans isolates, 60 C. dubliniensis isolates, and 82 isolates belonging to other species of yeast. The ICM albi-dubli test is based on the principle of immunochromatographic analysis and involves the use of two distinct monoclonal antibodies that recognize two unrelated epitopes expressed by both species or specific to only one species. The assay requires no complex instrumentation for analysis and can be recommended for routine use in clinical microbiology laboratories. Results are obtained within 2 h and 30 min and are easy to interpret. This evaluation demonstrated the good performance of this immunochromatographic test for C. albicans and C. dubliniensis isolated on Sabouraud dextrose agar, CHOROMagar Candida, and CandidaSelect, with sensitivities and specificities ranging from 93.1 to 100%. These parameters decreased, however, to 91.4% when the test was performed with yeast isolated with Candida ID.


  • New Monoclonal Antibody Specific for Candida albicans Germ Tube

    by Agnes Marot-Leblond, Linda Grimaud, Sandrine Nail, Sandrine Bouterige, Veronique Apaire-Marchais, Derek J. Sullivan, Raymond Robert

    Hydrophobic components of the germ tube of the dimorphic pathogenic fungus Candida albicans were used as immunogens to prepare monoclonal antibodies (MAbs). Among the resulting MAbs, one (MAb 16B1-F10) was shown by indirect immunofluorescence to be specific to the surface of the mycelium phase of the C. albicans and C. stellatoidea species. No labeling of any other genera and Candida species tested was observed, including C. dubliniensis, a newly described species which has many phenotypic similarities to C. albicans. This phase-specific epitope resides on a protein moiety. The molecular mass of the antigen released by Zymolyase digestion was determined by gel filtration and ranges from 25 to 166 kDa. The antigen was also shown to be highly hydrophobic. This anti-C. albicans cell wall surface-specific MAb may be a good candidate for use in tests for the rapid differentiation of the two closely related species C. albicans and C. dubliniensis.


  • Identification and immunochemical characterization of a germ tube specific antigen of Candida albicans

    by Agnès Marot-Leblond, Raymond Robert, Jacques Aubry, Pilar Ezcurra, Jean-Marcel Senet